-
1
-
-
0042991448
-
Use of pharmacoeconomics information. Report of the ISPOR Task Force on Use of Pharmacoeconomics/Health Economics Information in Health-Care Decision Making
-
Drummond M, Brown R, Fendrick AM, Fullerton P, Neumann P, Taylor R, et al. Use of pharmacoeconomics information. Report of the ISPOR Task Force on Use of Pharmacoeconomics/Health Economics Information in Health-Care Decision Making. Value Health 2003;6:407-16.
-
(2003)
Value Health
, vol.6
, pp. 407-416
-
-
Drummond, M.1
Brown, R.2
Fendrick, A.M.3
Fullerton, P.4
Neumann, P.5
Taylor, R.6
-
2
-
-
0025937985
-
Oregon's methods: Did cost-effectiveness analysis fail?
-
Eddy DM. Oregon's methods: did cost-effectiveness analysis fail? JAMA 1991;15:2135-41.
-
(1991)
JAMA
, vol.15
, pp. 2135-2141
-
-
Eddy, D.M.1
-
3
-
-
2442597011
-
El análisis coste-efectividad en la evaluación económica de intervenciones sanitarias
-
Prieto L, Sacristán JA, Antoñanzas F, Rubio-Terrés C, Pinto JL, Rovira J. El análisis coste-efectividad en la evaluación económica de intervenciones sanitarias. Med Clin (Barc) 2004;122:505-10.
-
(2004)
Med Clin (Barc)
, vol.122
, pp. 505-510
-
-
Prieto, L.1
Sacristán, J.A.2
Antoñanzas, F.3
Rubio-Terrés, C.4
Pinto, J.L.5
Rovira, J.6
-
5
-
-
0003866632
-
-
Ottawa: CCOHTA
-
nd ed. Ottawa: CCOHTA, 1997.
-
(1997)
nd Ed.
-
-
-
6
-
-
0012485416
-
Use of pharmacoeconomic data by regulatory authorities
-
Spilker B, editor. Philadelphia: Lippincott-Raven Publishers
-
Glasziou P, Mitchell A. Use of pharmacoeconomic data by regulatory authorities. En: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Publishers, 1996.
-
(1996)
Quality of Life and Pharmacoeconomics in Clinical Trials
-
-
Glasziou, P.1
Mitchell, A.2
-
8
-
-
85030884717
-
-
U.K. National Health Service. National Institute for Clinical Excellence. Disponible en: www.nice.org.uk
-
-
-
-
9
-
-
0033539236
-
NICE to rule on influenza flu drug zanamivir
-
Yamey G. NICE to rule on influenza flu drug zanamivir. BMJ 1999;319:942.
-
(1999)
BMJ
, vol.319
, pp. 942
-
-
Yamey, G.1
-
10
-
-
0037270120
-
The fourth hurdle as controlling instrument for expenditure on medication?
-
Kulp W, Greiner W, Von der Schulenburg JM. The fourth hurdle as controlling instrument for expenditure on medication? Eur J Health Econ 2003;4:1-5.
-
(2003)
Eur J Health Econ
, vol.4
, pp. 1-5
-
-
Kulp, W.1
Greiner, W.2
Von Der Schulenburg, J.M.3
-
11
-
-
0029096271
-
Economic analysis of health technologies and programes. A Spanish proposal for methodological standardisation
-
Rovira J, Antoñanzas F. Economic analysis of health technologies and programes. A Spanish proposal for methodological standardisation. Pharmacoeconomics 1995;8:245-52.
-
(1995)
Pharmacoeconomics
, vol.8
, pp. 245-252
-
-
Rovira, J.1
Antoñanzas, F.2
-
12
-
-
0043033163
-
Challenges to achieving values in drug spending in a decentralized country: The Spanish case
-
Antoñanzas F. Challenges to achieving values in drug spending in a decentralized country: the Spanish case. Value Health 2003;6(Suppl 1):52-63.
-
(2003)
Value Health
, vol.6
, Issue.SUPPL. 1
, pp. 52-63
-
-
Antoñanzas, F.1
-
13
-
-
3142666474
-
Análisis de las evaluaciones económicas de tecnologías sanitarias realizadas en España en la década 1990-2000
-
Oliva J, Del Llano J, Sacristán JA. Análisis de las evaluaciones económicas de tecnologías sanitarias realizadas en España en la década 1990-2000. Gac Sanit 2003;16(Supl 2):2-11.
-
(2003)
Gac Sanit
, vol.16
, Issue.SUPPL. 2
, pp. 2-11
-
-
Oliva, J.1
Del Llano, J.2
Sacristán, J.A.3
-
14
-
-
0035673194
-
Twenty years of health care economic analysis in Spain: Are we doing well?
-
García-Altés A. Twenty years of health care economic analysis in Spain: are we doing well? Health Econ 2001;10:715-9.
-
(2001)
Health Econ
, vol.10
, pp. 715-719
-
-
García-Altés, A.1
-
15
-
-
85030884437
-
-
Ley 16/2003 de 28 de mayo de cohesión y calidad del Sistema Nacional de Salud
-
Ley 16/2003 de 28 de mayo de cohesión y calidad del Sistema Nacional de Salud.
-
-
-
-
16
-
-
0041530262
-
The drug budget silo mentality in Europe: An overview
-
Garrison L, Towse A. The drug budget silo mentality in Europe: an overview. Value Health 2003;6(Suppl 1):1-9.
-
(2003)
Value Health
, vol.6
, Issue.SUPPL. 1
, pp. 1-9
-
-
Garrison, L.1
Towse, A.2
-
17
-
-
0034034660
-
The influence of economic evaluations studies on decision making. A European survey
-
Hoffmann C, Graf von der Schulenburg JM. The influence of economic evaluations studies on decision making. A European survey. Health Policy 2000;52:179-92.
-
(2000)
Health Policy
, vol.52
, pp. 179-192
-
-
Hoffmann, C.1
Graf Von Der Schulenburg, J.M.2
-
18
-
-
0042206385
-
Moving beyond the drug budget silo mentality in Europe
-
Drummond M, Jönsson B. Moving beyond the drug budget silo mentality in Europe. Value Health 2003;6(Suppl 1):74-7.
-
(2003)
Value Health
, vol.6
, Issue.SUPPL. 1
, pp. 74-77
-
-
Drummond, M.1
Jönsson, B.2
-
19
-
-
0042991448
-
Use of pharmacoeconomics information. Report of the ISPOR Task Force on Use of Pharmacoeconomics/Health Economics Information in Health-Care Decision Making
-
Drummond M, Brown R, Fendrick AM, Fullerton P, Neumann P, Taylor R, et al. Use of pharmacoeconomics information. Report of the ISPOR Task Force on Use of Pharmacoeconomics/Health Economics Information in Health-Care Decision Making. Value Health 2003;6:407-16.
-
(2003)
Value Health
, vol.6
, pp. 407-416
-
-
Drummond, M.1
Brown, R.2
Fendrick, A.M.3
Fullerton, P.4
Neumann, P.5
Taylor, R.6
-
20
-
-
0034945594
-
Health economic guidelines. Similarities, differences and some implications
-
Hjelmgren J, Berggren F, Anderson F. Health economic guidelines. Similarities, differences and some implications. Value Health 2001;4:225-50.
-
(2001)
Value Health
, vol.4
, pp. 225-250
-
-
Hjelmgren, J.1
Berggren, F.2
Anderson, F.3
-
21
-
-
85084767888
-
Publication bias in health economic studies
-
Sacristán JA, Bolaños E, Hernández JM, Soto J, Galende I. Publication bias in health economic studies. Pharmacoeconomics 1997;11:289-90.
-
(1997)
Pharmacoeconomics
, vol.11
, pp. 289-290
-
-
Sacristán, J.A.1
Bolaños, E.2
Hernández, J.M.3
Soto, J.4
Galende, I.5
-
22
-
-
0037280384
-
Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR Task Force on Good Research Practices - Modeling studies
-
Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling studies. Value Health 2003;6:9-17.
-
(2003)
Value Health
, vol.6
, pp. 9-17
-
-
Weinstein, M.C.1
O'Brien, B.2
Hornberger, J.3
Jackson, J.4
Johannesson, M.5
McCabe, C.6
-
23
-
-
0037357132
-
A checklist for retrospective database studies. Report of the ISPOR Task Force on Retrospective Databases
-
Motheral B, Brooks J, Clark MA, Crown WH, Davey P, Hutchins D, et al. A checklist for retrospective database studies. Report of the ISPOR Task Force on Retrospective Databases. Value Health 2003;6:90-7.
-
(2003)
Value Health
, vol.6
, pp. 90-97
-
-
Motheral, B.1
Brooks, J.2
Clark, M.A.3
Crown, W.H.4
Davey, P.5
Hutchins, D.6
-
24
-
-
0037930229
-
Modeling the cost-effectiveness and budgetary impact for subpopulations
-
Nuijten MJC, Kosa J, Engelfriet P. Modeling the cost-effectiveness and budgetary impact for subpopulations. Eur J Health Econom 2003;4:70-8.
-
(2003)
Eur J Health Econom
, vol.4
, pp. 70-78
-
-
Nuijten, M.J.C.1
Kosa, J.2
Engelfriet, P.3
-
25
-
-
0031945970
-
Extrapolation of cost-effectiveness information to local settings
-
Bryan S, Brown J. Extrapolation of cost-effectiveness information to local settings. J Health Serv Res Policy 1998;3:108-12.
-
(1998)
J Health Serv Res Policy
, vol.3
, pp. 108-112
-
-
Bryan, S.1
Brown, J.2
-
27
-
-
0035586112
-
NICE: Faster access to modern treatments? Analysis of guidance on health technologies
-
Raftery J. NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 2001;323:1300-3.
-
(2001)
BMJ
, vol.323
, pp. 1300-1303
-
-
Raftery, J.1
-
29
-
-
0010178771
-
Are pharmaceuticals cost-effective? A review of the evidence
-
Neumann PJ, Sandberg EA, Bell CM, Stone PW, Chapman RH. Are pharmaceuticals cost-effective? A review of the evidence. Health Affairs 2000;19:92-109.
-
(2000)
Health Affairs
, vol.19
, pp. 92-109
-
-
Neumann, P.J.1
Sandberg, E.A.2
Bell, C.M.3
Stone, P.W.4
Chapman, R.H.5
-
30
-
-
0041807885
-
What is the price of life and why doesn't it increase at the rate of inflation?
-
Ubel PA. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 2003;163:1637-41.
-
(2003)
Arch Intern Med
, vol.163
, pp. 1637-1641
-
-
Ubel, P.A.1
-
31
-
-
0037930215
-
Changes in cost-effectiveness over time. The case of epoetin alfa for renal replacement therapy patients in the UK
-
Remák E, Hutton J, Zagari M. Changes in cost-effectiveness over time. The case of epoetin alfa for renal replacement therapy patients in the UK. Eur J Health Econom 2003;4:115-21.
-
(2003)
Eur J Health Econom
, vol.4
, pp. 115-121
-
-
Remák, E.1
Hutton, J.2
Zagari, M.3
-
32
-
-
0345828577
-
¿Qué es una tecnología sanitaria eficiente en España?
-
Sacristán JA, Oliva J, Del Llano J, Prieto L, Pinto JL. ¿Qué es una tecnología sanitaria eficiente en España? Gac Sanit 2002;16:334-43.
-
(2002)
Gac Sanit
, vol.16
, pp. 334-343
-
-
Sacristán, J.A.1
Oliva, J.2
Del Llano, J.3
Prieto, L.4
Pinto, J.L.5
-
33
-
-
0037029325
-
From guidance to practice: Why NICE is not enough
-
Dent THS, Sadler M. From guidance to practice: why NICE is not enough. BMJ 2002;324:842-5.
-
(2002)
BMJ
, vol.324
, pp. 842-845
-
-
Dent, T.H.S.1
Sadler, M.2
-
34
-
-
0033756058
-
Equity in the allocation of health care resources
-
Sheldon TA, Smith PC. Equity in the allocation of health care resources. Health Econ 2000;9:571-4.
-
(2000)
Health Econ
, vol.9
, pp. 571-574
-
-
Sheldon, T.A.1
Smith, P.C.2
-
35
-
-
0029979686
-
Cost-effectiveness analysis in a setting of budget constrains. Is it equitable?
-
Ubel PA, DeKay ML, Baron J, Asch DA. Cost-effectiveness analysis in a setting of budget constrains. Is it equitable? N Engl J Med 1996;334:1174-7.
-
(1996)
N Engl J Med
, vol.334
, pp. 1174-1177
-
-
Ubel, P.A.1
DeKay, M.L.2
Baron, J.3
Asch, D.A.4
-
36
-
-
0037375101
-
The influence of cost-effectiveness information on physicians' cancer screening recommendations
-
Ubel PA, Jepson C, Baron J, Hersey JC, Asch DA. The influence of cost-effectiveness information on physicians' cancer screening recommendations. Soc Sci Med 2003;56:1727-36.
-
(2003)
Soc Sci Med
, vol.56
, pp. 1727-1736
-
-
Ubel, P.A.1
Jepson, C.2
Baron, J.3
Hersey, J.C.4
Asch, D.A.5
-
37
-
-
3142747118
-
Impacto de los estudios de evaluación económica en la toma de decisiones en atención primaria
-
Oliva J, Del Llano J, Antoñanzas F, Juárez C, Rovira J, Figueras M, et al. Impacto de los estudios de evaluación económica en la toma de decisiones en atención primaria. Cuadernos de Gestión 2001;7:192-202.
-
(2001)
Cuadernos de Gestión
, vol.7
, pp. 192-202
-
-
Oliva, J.1
Del Llano, J.2
Antoñanzas, F.3
Juárez, C.4
Rovira, J.5
Figueras, M.6
-
38
-
-
3142714788
-
Impacto de los estudios de evaluación económica en la toma de decisiones sanitarias en el ámbito hospitalario
-
Oliva J, Del Llano J, Antoñanzas F, Juárez C, Rovira J, Figueras M. Impacto de los estudios de evaluación económica en la toma de decisiones sanitarias en el ámbito hospitalario. Gestión Hospitalaria 2000;11:171-9.
-
(2000)
Gestión Hospitalaria
, vol.11
, pp. 171-179
-
-
Oliva, J.1
Del Llano, J.2
Antoñanzas, F.3
Juárez, C.4
Rovira, J.5
Figueras, M.6
-
39
-
-
2342557942
-
La evaluación económica en medicina
-
Sacristán JA, Ortún V, Rovira J, Prieto L, García-Alonso F. La evaluación económica en medicina. Med Clin (Barc) 2004;122:379-82.
-
(2004)
Med Clin (Barc)
, vol.122
, pp. 379-382
-
-
Sacristán, J.A.1
Ortún, V.2
Rovira, J.3
Prieto, L.4
García-Alonso, F.5
-
40
-
-
0026769778
-
Cost-effectiveness analysis. Will it be accepted?
-
Eddy DM. Cost-effectiveness analysis. Will it be accepted? JAMA 1992;268:132-6.
-
(1992)
JAMA
, vol.268
, pp. 132-136
-
-
Eddy, D.M.1
-
41
-
-
85030875797
-
Evaluación económica, establecimiento de prioridades y racionamiento del gasto en sanidad
-
Haymarker S.A
-
Rovira J. Evaluación económica, establecimiento de prioridades y racionamiento del gasto en sanidad. En: Toma de decisiones clínicas: de la teoría a la práctica. Haymarker S.A., 1993.
-
(1993)
Toma de Decisiones Clínicas: De la Teoría a la Práctica
-
-
Rovira, J.1
-
43
-
-
0012555408
-
Los costes de las actuaciones médicas inadecuadas
-
Meneu R. Los costes de las actuaciones médicas inadecuadas. FMC Aten Primaria 2000;7:378-85.
-
(2000)
FMC Aten Primaria
, vol.7
, pp. 378-385
-
-
Meneu, R.1
-
44
-
-
0036835595
-
Incorporating economic analysis into clinical practice guidelines: A guide for users
-
Ramsey SD. Incorporating economic analysis into clinical practice guidelines: a guide for users. ACP J Club 2002;137:A11.
-
(2002)
ACP J Club
, vol.137
-
-
Ramsey, S.D.1
-
45
-
-
0035974488
-
Summarising economic evaluations in systematic reviews: A new approach
-
Nixon J, Khan KS, Kleijnen J. Summarising economic evaluations in systematic reviews: a new approach. BMJ 2001;322:1596-8.
-
(2001)
BMJ
, vol.322
, pp. 1596-1598
-
-
Nixon, J.1
Khan, K.S.2
Kleijnen, J.3
-
46
-
-
0003702642
-
Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid?
-
Drummond MF, Richardson WS, O'Brien BJ, Levine M. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? JAMA 1997;277:1552-7.
-
(1997)
JAMA
, vol.277
, pp. 1552-1557
-
-
Drummond, M.F.1
Richardson, W.S.2
O'Brien, B.J.3
Levine, M.4
-
47
-
-
0030925714
-
Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients?
-
O'Brien BJ, Heyland D, Richardson WS, Levine M, Drummond MF. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? JAMA 1997;277:1802-6.
-
(1997)
JAMA
, vol.277
, pp. 1802-1806
-
-
O'Brien, B.J.1
Heyland, D.2
Richardson, W.S.3
Levine, M.4
Drummond, M.F.5
-
49
-
-
0026526874
-
Cost-effectiveness analyses in the medical literature. Are the methods being used correctly?
-
Udvarheyi IS, Colditz GA, Rai A, Epstein MP. Cost-effectiveness analyses in the medical literature. Are the methods being used correctly? Ann Intern Med 1992;116:238-44.
-
(1992)
Ann Intern Med
, vol.116
, pp. 238-244
-
-
Udvarheyi, I.S.1
Colditz, G.A.2
Rai, A.3
Epstein, M.P.4
-
50
-
-
0029063563
-
Economic analysis of health care technology: A report on principles
-
Task force on principles for economic analysis of healthcare technology. Economic analysis of health care technology: a report on principles. Ann Intern Med 1995;122:61-70.
-
(1995)
Ann Intern Med
, vol.122
, pp. 61-70
-
-
-
51
-
-
0029093028
-
Methodological and conduct principles for pharmacoeconomic research
-
Pharmaceutical Research and Manufacturers of America
-
Clemens K, Towsend R, Luscombe F, Mauskopf J, Osterhaus J, Bobula J. Methodological and conduct principles for pharmacoeconomic research. Pharmaceutical Research and Manufacturers of America. Pharmacoeconomics 1995;8:169-74.
-
(1995)
Pharmacoeconomics
, vol.8
, pp. 169-174
-
-
Clemens, K.1
Towsend, R.2
Luscombe, F.3
Mauskopf, J.4
Osterhaus, J.5
Bobula, J.6
-
52
-
-
0033567212
-
Applied pharmacoeconomics: Evaluation and use of pharmacoeconomic data from the literature
-
Sánchez LA. Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature. Am J Health Syst Pharm 1999;56:1630-8.
-
(1999)
Am J Health Syst Pharm
, vol.56
, pp. 1630-1638
-
-
Sánchez, L.A.1
-
53
-
-
0027363220
-
Evaluation of pharmacoeconomic studies: Utilization of a checklist
-
Sacristán JA, Soto J, Galende I. Evaluation of pharmacoeconomic studies: utilization of a checklist. Ann Pharmacother 1993;27:1126-33.
-
(1993)
Ann Pharmacother
, vol.27
, pp. 1126-1133
-
-
Sacristán, J.A.1
Soto, J.2
Galende, I.3
-
54
-
-
0029143993
-
Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals
-
Bradley CA, Iskedjian M, Lanctot KL, Mittmann N, Simone C, St Pierre E, et al. Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals. Ann Pharmacother 1995;29:681-9.
-
(1995)
Ann Pharmacother
, vol.29
, pp. 681-689
-
-
Bradley, C.A.1
Iskedjian, M.2
Lanctot, K.L.3
Mittmann, N.4
Simone, C.5
St Pierre, E.6
-
55
-
-
0030726292
-
Quality assessment of economic evaluations published in Pharmacoeconomics: The first four years (1992 to 1995)
-
Iskedjian M, Trakas K, Bradley CA, Addis A, Lanctot K, Kruk D, et al. Quality assessment of economic evaluations published in Pharmacoeconomics: the first four years (1992 to 1995). Pharmacoeconomics 1997;12:685-94.
-
(1997)
Pharmacoeconomics
, vol.12
, pp. 685-694
-
-
Iskedjian, M.1
Trakas, K.2
Bradley, C.A.3
Addis, A.4
Lanctot, K.5
Kruk, D.6
-
56
-
-
0034674047
-
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics
-
Prosser L, Stinnett AA, Goldman PA, Williams LW, Hunink MGM, Goldman L, et al. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med 2000;132:769-79.
-
(2000)
Ann Intern Med
, vol.132
, pp. 769-779
-
-
Prosser, L.1
Stinnett, A.A.2
Goldman, P.A.3
Williams, L.W.4
Hunink, M.G.M.5
Goldman, L.6
-
57
-
-
0031034580
-
Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain
-
Plans P. Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain. Public Health 1997;111:33-40.
-
(1997)
Public Health
, vol.111
, pp. 33-40
-
-
Plans, P.1
-
59
-
-
0025716094
-
De la efectividad clínica a la eficiencia social
-
Ortún V, Rodríguez Artalejo F. De la efectividad clínica a la eficiencia social. Med Clin (Barc) 1990;95:385-8.
-
(1990)
Med Clin (Barc)
, vol.95
, pp. 385-388
-
-
Ortún, V.1
Rodríguez Artalejo, F.2
-
60
-
-
0025339544
-
A clinician's guide to cost-effectiveness analysis
-
Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990;113:147-54.
-
(1990)
Ann Intern Med
, vol.113
, pp. 147-154
-
-
Detsky, A.S.1
Naglie, I.G.2
|